Target Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Files a patent infringement suit Nov. 9 in U.S. District Court in San Francisco against SciMed Life Systems and Cordis Endovascular Systems. The Fremont, California-based manufacturer alleges that SciMed's Venture intravascular infusion catheter and Transend guidewire and Cordis' Transit infusion catheter and Instinct steerable guidewire infringe Target's patent No. 4,739,768, "A Catheter for Guide-Wire Tracking." Patent "768 covers the principal technology in Target's FasTracker micro- catheters. The company seeks treble damages and a permanent injunction against the sale of Cordis' and SciMed's allegedly infringing products